Monoclonal antibodies (mAbs) are biological agents that are widely used to treat malignancies including non-Hodgkin's lymphomas and chronic lymphocytic leukaemia. The patents for many mAbs are expiring, so biosimilar medicines, which contain a version of the active ingredient of the original drug, are being developed.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Biosimilar Monoclonal Antibodies industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Infliximab
Rituximab
Trastuzumab
Adalimumab
Other
Market Segment by Product Application
Oncology
Autoimmune Disease
Other
Finally, the report provides detailed profile and data information analysis of leading company.
Celltrion
Hisun Pharma
Novartis (Sandoz)
Pfizer (Hospira)
Cadila Healthcare
3SBIO
Celgen Biopharma
Dr Reddy's
Torrent Pharmaceuticals
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Biosimilar Monoclonal Antibodies consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Biosimilar Monoclonal Antibodies market by identifying its various subsegments.
3.Focuses on the key global Biosimilar Monoclonal Antibodies manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Biosimilar Monoclonal Antibodies with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Biosimilar Monoclonal Antibodies submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Biosimilar Monoclonal Antibodies Professional Survey Report Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Biosimilar Monoclonal Antibodies Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Biosimilar Monoclonal Antibodies Segment by Type
2.1.1 Infliximab
2.1.2 Rituximab
2.1.3 Trastuzumab
2.1.4 Adalimumab
2.1.5 Other
2.2 Market Analysis by Application
2.2.1 Oncology
2.2.2 Autoimmune Disease
2.2.3 Other
2.3 Global Biosimilar Monoclonal Antibodies Market Comparison by Regions (2017-2027)
2.3.1 Global Biosimilar Monoclonal Antibodies Market Size (2017-2027)
2.3.2 North America Biosimilar Monoclonal Antibodies Status and Prospect (2017-2027)
2.3.3 Europe Biosimilar Monoclonal Antibodies Status and Prospect (2017-2027)
2.3.4 Asia-pacific Biosimilar Monoclonal Antibodies Status and Prospect (2017-2027)
2.3.5 South America Biosimilar Monoclonal Antibodies Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Biosimilar Monoclonal Antibodies Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Biosimilar Monoclonal Antibodies Industry Impact
2.5.1 Biosimilar Monoclonal Antibodies Business Impact Assessment - Covid-19
2.5.2 Market Trends and Biosimilar Monoclonal Antibodies Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Biosimilar Monoclonal Antibodies Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Biosimilar Monoclonal Antibodies Manufacturer Market Share
3.5 Top 10 Biosimilar Monoclonal Antibodies Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Biosimilar Monoclonal Antibodies Market
3.7 Key Manufacturers Biosimilar Monoclonal Antibodies Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Biosimilar Monoclonal Antibodies Industry Key Manufacturers
4.1 Celltrion
4.1.1 Company Details
4.1.2 Celltrion Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
4.1.3 Celltrion Biosimilar Monoclonal Antibodies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Celltrion News
4.2 Hisun Pharma
4.2.1 Company Details
4.2.2 Hisun Pharma Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
4.2.3 Hisun Pharma Biosimilar Monoclonal Antibodies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Hisun Pharma News
4.3 Novartis (Sandoz)
4.3.1 Company Details
4.3.2 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
4.3.3 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Novartis (Sandoz) News
4.4 Pfizer (Hospira)
4.4.1 Company Details
4.4.2 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
4.4.3 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Pfizer (Hospira) News
4.5 Cadila Healthcare
4.5.1 Company Details
4.5.2 Cadila Healthcare Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
4.5.3 Cadila Healthcare Biosimilar Monoclonal Antibodies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Cadila Healthcare News
4.6 3SBIO
4.6.1 Company Details
4.6.2 3SBIO Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
4.6.3 3SBIO Biosimilar Monoclonal Antibodies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 3SBIO News
4.7 Celgen Biopharma
4.7.1 Company Details
4.7.2 Celgen Biopharma Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
4.7.3 Celgen Biopharma Biosimilar Monoclonal Antibodies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 Celgen Biopharma News
4.8 Dr Reddy's
4.8.1 Company Details
4.8.2 Dr Reddy's Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
4.8.3 Dr Reddy's Biosimilar Monoclonal Antibodies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Dr Reddy's News
4.9 Torrent Pharmaceuticals
4.9.1 Company Details
4.9.2 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
4.9.3 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Torrent Pharmaceuticals News
5 Global Biosimilar Monoclonal Antibodies Sales Categorized by Regions
5.1 Global Biosimilar Monoclonal Antibodies Revenue, Sales and Market Share by Regions
5.1.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Regions (2017-2022)
5.1.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Regions (2017-2022)
5.2 North America Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
5.3 Europe Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
5.4 Asia-pacific Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
5.5 South America Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
5.6 Middle East & Africa Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
6 North America Biosimilar Monoclonal Antibodies Market Size Categorized by Countries
6.1 North America Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Countries
6.1.1 North America Biosimilar Monoclonal Antibodies Sales (Volume) by Countries (2017-2022)
6.1.2 North America Biosimilar Monoclonal Antibodies Revenue by Countries (2017-2022)
6.1.3 United States Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
6.1.4 Canada Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
6.1.5 Mexico Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
6.2 North America Biosimilar Monoclonal Antibodies Revenue (Value) by Manufacturers
6.3 North America Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2017-2022)
6.4 North America Biosimilar Monoclonal Antibodies Sales Market Share by Application (2017-2022)
7 Europe Biosimilar Monoclonal Antibodies Market Size Categorized by Countries
7.1 Europe Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Countries
7.1.1 Europe Biosimilar Monoclonal Antibodies Sales (Volume) by Countries (2017-2022)
7.1.2 Europe Biosimilar Monoclonal Antibodies Revenue by Countries (2017-2022)
7.1.3 Germany Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
7.1.4 UK Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
7.1.5 France Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
7.1.6 Russia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
7.1.7 Italy Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
7.1.8 Spain Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
7.2 Europe Biosimilar Monoclonal Antibodies Revenue (Value) by Manufacturers
7.3 Europe Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2017-2022)
7.4 Europe Biosimilar Monoclonal Antibodies Sales Market Share by Application (2017-2022)
8 Asia-Pacific Biosimilar Monoclonal Antibodies Market Size Categorized by Countries
8.1 Asia-pacific Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Biosimilar Monoclonal Antibodies Sales (Volume) by Countries (2017-2022)
8.1.2 Asia-pacific Biosimilar Monoclonal Antibodies Revenue by Countries (2017-2022)
8.1.3 China Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
8.1.4 South Korea Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
8.1.5 Japan Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
8.1.6 Australia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
8.1.7 India Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
8.1.8 Southeast Asia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
8.2 Asia-pacific Biosimilar Monoclonal Antibodies Revenue (Value) by Manufacturers
8.3 Asia-pacific Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2017-2022)
8.4 Asia-pacific Biosimilar Monoclonal Antibodies Sales Market Share by Application (2017-2022)
9 South America Biosimilar Monoclonal Antibodies Market Size Categorized by Countries
9.1 South America Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Countries
9.1.1 South America Biosimilar Monoclonal Antibodies Sales (Volume) by Countries (2017-2022)
9.1.2 South America Biosimilar Monoclonal Antibodies Revenue by Countries (2017-2022)
9.1.3 Brazil Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
9.2 South America Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2017-2022)
9.3 South America Biosimilar Monoclonal Antibodies Sales Market Share by Application (2017-2022)
10 Middle East and Africa Biosimilar Monoclonal Antibodies Market Size Categorized by Countries
10.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales (Volume) by Countries (2017-2022)
10.1.2 Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Countries (2017-2022)
10.1.3 GCC Countries Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
10.1.4 Turkey Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
10.1.5 Egypt Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
10.1.6 South America Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
10.2 Middle East and Africa Biosimilar Monoclonal Antibodies Sales and Market Share by Type
10.3 Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Application (2017-2022)
11 Global Biosimilar Monoclonal Antibodies Market Segment by Type
11.1 Global Biosimilar Monoclonal Antibodies Revenue, Sales and Market Share by Type (2017-2022)
11.1.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2017-2022)
11.1.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2017-2022)
11.2 Infliximab Sales Growth Rate and Price
11.2.1 Global Infliximab Sales Growth Rate (2017-2022)
11.2.2 Global Infliximab Price (2017-2022)
11.3 Rituximab Sales Growth Rate and Price
11.3.1 Global Rituximab Sales Growth Rate (2017-2022)
11.3.2 Global Rituximab Price (2017-2022)
11.4 Trastuzumab Sales Growth Rate and Price
11.4.1 Global Trastuzumab Sales Growth Rate (2017-2022)
11.4.2 Global Trastuzumab Price (2017-2022)
11.5.1 Global Adalimumab Sales Growth Rate (2017-2022)
11.5.2 Global Adalimumab Price (2017-2022)
11.6 Other Sales Growth Rate and Price
11.6.1 Global Other Sales Growth Rate (2017-2022)
11.6.2 Global Other Price (2017-2022)
12 Global Biosimilar Monoclonal Antibodies Market Segment by Application
12.1 Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2017-2022)
12.2 Oncology Sales Growth Rate (2017-2022)
12.3 Autoimmune Disease Sales Growth Rate (2017-2022)
12.4 Other Sales Growth Rate (2017-2022)
13 Global Biosimilar Monoclonal Antibodies Market Forecast
13.1 Global Biosimilar Monoclonal Antibodies Revenue, Sales and Growth Rate (2022-2027)
13.2 Biosimilar Monoclonal Antibodies Market Forecast by Regions (2022-2027)
13.2.1 North America Biosimilar Monoclonal Antibodies Market Forecast (2022-2027)
13.2.2 Europe Biosimilar Monoclonal Antibodies Market Forecast (2022-2027)
13.2.3 Asia-Pacific Biosimilar Monoclonal Antibodies Market Forecast (2022-2027)
13.2.4 South America Biosimilar Monoclonal Antibodies Market Forecast (2022-2027)
13.2.5 Middle East & Africa Biosimilar Monoclonal Antibodies Market Forecast (2022-2027)
13.3 Biosimilar Monoclonal Antibodies Market Forecast by Type (2022-2027)
13.3.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Type (2022-2027)
13.3.2 Global Biosimilar Monoclonal Antibodies Market Share Forecast by Type (2022-2027)
13.4 Biosimilar Monoclonal Antibodies Market Forecast by Application (2022-2027)
13.4.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Application (2022-2027)
13.4.2 Global Biosimilar Monoclonal Antibodies Market Share Forecast by Application (2022-2027)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Biosimilar Monoclonal Antibodies Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Biosimilar Monoclonal Antibodies Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture Biosimilar Monoclonal Antibodies
Figure Market Concentration Ratio and Market Maturity Analysis of Biosimilar Monoclonal Antibodies
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Biosimilar Monoclonal Antibodies Market Size by Type
Figure Global Market Share of Biosimilar Monoclonal Antibodies by Type in 2021
Figure Infliximab Picture
Figure Rituximab Picture
Figure Trastuzumab Picture
Figure Adalimumab Picture
Figure Other Picture
Table Global Biosimilar Monoclonal Antibodies Market Size (Volume) by Application
Figure Oncology Picture
Figure Autoimmune Disease Picture
Figure Other Picture
Table Global Biosimilar Monoclonal Antibodies Comparison by Regions (M USD) 2017-2027
Figure Global Biosimilar Monoclonal Antibodies Market Size (Million US$) (2017-2027)
Figure North America Biosimilar Monoclonal Antibodies Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Biosimilar Monoclonal Antibodies Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific Biosimilar Monoclonal Antibodies Revenue (Million US$) Growth Rate (2017-2027)
Figure South America Biosimilar Monoclonal Antibodies Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa Biosimilar Monoclonal Antibodies Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Biosimilar Monoclonal Antibodies Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Biosimilar Monoclonal Antibodies Sales by Manufacturer (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Manufacturer in 2021
Table Global Biosimilar Monoclonal Antibodies Revenue by Manufacturer (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Manufacturer in 2021
Table Global Biosimilar Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Biosimilar Monoclonal Antibodies Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Biosimilar Monoclonal Antibodies Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Biosimilar Monoclonal Antibodies Market
Table Key Manufacturers Biosimilar Monoclonal Antibodies Product Type
Table Mergers & Acquisitions Planning
Table Celltrion Company Profile
Table Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification of Celltrion
Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Celltrion 2017-2022
Table Celltrion Main Business
Table Celltrion Recent Development
Table Hisun Pharma Company Profile
Table Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification of Hisun Pharma
Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Hisun Pharma 2017-2022
Table Hisun Pharma Main Business
Table Hisun Pharma Recent Development
Table Novartis (Sandoz) Company Profile
Table Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification of Novartis (Sandoz)
Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Novartis (Sandoz) 2017-2022
Table Novartis (Sandoz) Main Business
Table Novartis (Sandoz) Recent Development
Table Pfizer (Hospira) Company Profile
Table Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification of Pfizer (Hospira)
Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer (Hospira) 2017-2022
Table Pfizer (Hospira) Main Business
Table Pfizer (Hospira) Recent Development
Table Cadila Healthcare Company Profile
Table Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification of Cadila Healthcare
Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Cadila Healthcare 2017-2022
Table Cadila Healthcare Main Business
Table Cadila Healthcare Recent Development
Table 3SBIO Company Profile
Table Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification of 3SBIO
Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of 3SBIO 2017-2022
Table 3SBIO Main Business
Table 3SBIO Recent Development
Table Celgen Biopharma Company Profile
Table Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification of Celgen Biopharma
Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Celgen Biopharma 2017-2022
Table Celgen Biopharma Main Business
Table Celgen Biopharma Recent Development
Table Dr Reddy's Company Profile
Table Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification of Dr Reddy's
Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Dr Reddy's 2017-2022
Table Dr Reddy's Main Business
Table Dr Reddy's Recent Development
Table Torrent Pharmaceuticals Company Profile
Table Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification of Torrent Pharmaceuticals
Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Torrent Pharmaceuticals 2017-2022
Table Torrent Pharmaceuticals Main Business
Table Torrent Pharmaceuticals Recent Development
Figure Global Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Sales by Regions (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Regions in 2021
Table Global Biosimilar Monoclonal Antibodies Revenue by Regions (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Regions in 2021
Figure North America Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure Europe Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure Asia-pacific Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure South America Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure Middle East & Africa Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure North America Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Table North America Biosimilar Monoclonal Antibodies Sales (Volume) by Countries (2017-2022)
Table North America Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2017-2022)
Figure North America Biosimilar Monoclonal Antibodies Sales Market Share by Countries in 2021
Table North America Biosimilar Monoclonal Antibodies Revenue by Countries (2017-2022)
Table North America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2017-2022)
Figure North America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries in 2021
Figure United States Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure Canada Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure Mexico Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Table North America Biosimilar Monoclonal Antibodies Revenue by Manufacturer (2021)
Figure North America Biosimilar Monoclonal Antibodies Revenue Market Share by Manufacturer in 2021
Table North America Biosimilar Monoclonal Antibodies Sales by Type (2017-2022)
Table North America Biosimilar Monoclonal Antibodies Sales Share by Type (2017-2022)
Table North America Biosimilar Monoclonal Antibodies Sales by Application (2017-2022)
Table North America Biosimilar Monoclonal Antibodies Sales Share by Application (2017-2022)
Figure Europe Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Table Europe Biosimilar Monoclonal Antibodies Sales (Volume) by Countries (2017-2022)
Table Europe Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2017-2022)
Figure Europe Biosimilar Monoclonal Antibodies Sales Market Share by Countries in 2021
Table Europe Biosimilar Monoclonal Antibodies Revenue by Countries (2017-2022)
Table Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2017-2022)
Figure Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Countries in 2021
Figure Germany Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure UK Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure France Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure Russia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure Italy Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure Spain Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Table Europe Biosimilar Monoclonal Antibodies Revenue by Manufacturer (2021)
Figure Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Manufacturer in 2021
Table Europe Biosimilar Monoclonal Antibodies Sales by Type (2017-2022)
Table Europe Biosimilar Monoclonal Antibodies Sales Share by Type (2017-2022)
Table Europe Biosimilar Monoclonal Antibodies Sales by Application (2017-2022)
Table Europe Biosimilar Monoclonal Antibodies Sales Share by Application (2017-2022)
Figure Asia-pacific Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Table Asia-pacific Biosimilar Monoclonal Antibodies Sales (Volume) by Countries (2017-2022)
Table Asia-pacific Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2017-2022)
Figure Asia-pacific Biosimilar Monoclonal Antibodies Sales Market Share by Countries in 2021
Table Asia-pacific Biosimilar Monoclonal Antibodies Revenue by Countries (2017-2022)
Table Asia-pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2017-2022)
Figure Asia-pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Countries in 2021
Figure China Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure South Korea Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure Japan Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure Australia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure India Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Table Asia-pacific Biosimilar Monoclonal Antibodies Revenue by Manufacturer (2021)
Figure Asia-pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Manufacturer in 2021
Table Asia-pacific Biosimilar Monoclonal Antibodies Sales by Type (2017-2022)
Table Asia-pacific Biosimilar Monoclonal Antibodies Sales Share by Type (2017-2022)
Table Asia-pacific Biosimilar Monoclonal Antibodies Sales by Application (2017-2022)
Table Asia-pacific Biosimilar Monoclonal Antibodies Sales Share by Application (2017-2022)
Figure South America Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Table South America Biosimilar Monoclonal Antibodies Sales (Volume) by Countries (2017-2022)
Table South America Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2017-2022)
Figure South America Biosimilar Monoclonal Antibodies Sales Market Share by Countries in 2019
Table South America Biosimilar Monoclonal Antibodies Revenue by Countries (2017-2022)
Table South America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2017-2022)
Figure South America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries in 2019
Figure Brazil Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Table South America Biosimilar Monoclonal Antibodies Sales by Type (2017-2022)
Table South America Biosimilar Monoclonal Antibodies Sales Share by Type (2017-2022)
Table South America Biosimilar Monoclonal Antibodies Revenue by Type (2017-2022)
Table South America Biosimilar Monoclonal Antibodies Revenue Share by Type (2017-2022)
Table South America Biosimilar Monoclonal Antibodies Sales by Application (2017-2022)
Table South America Biosimilar Monoclonal Antibodies Sales Share by Application (2017-2022)
Figure Middle East and Africa Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales (Volume) by Countries (2017-2022)
Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2017-2022)
Figure Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Countries in 2019
Table Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Countries (2017-2022)
Table Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2017-2022)
Figure Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Countries in 2019
Figure GCC Countries Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure Turkey Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure Egypt Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure South Africa Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Type (2017-2022)
Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales Share by Type (2017-2022)
Table Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Type (2017-2022)
Table Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Share by Type (2017-2022)
Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Application (2017-2022)
Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales Share by Application (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Sales by Type (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Type (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2021
Table Global Biosimilar Monoclonal Antibodies Revenue by Type (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type in 2019
Figure Global Infliximab Sales Growth Rate (2017-2022)
Figure Global Infliximab Price (2017-2022)
Figure Global Rituximab Sales Growth Rate (2017-2022)
Figure Global Rituximab Price (2017-2022)
Figure Global Trastuzumab Sales Growth Rate (2017-2022)
Figure Global Trastuzumab Price (2017-2022)
Figure Global Adalimumab Sales Growth Rate (2017-2022)
Figure Global Adalimumab Price (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Figure Global Other Price (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Sales by Application (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2021
Figure Global Oncology Sales Growth Rate (2017-2022)
Figure Global Autoimmune Disease Sales Growth Rate (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Sales and Growth Rate (2022-2027)
Figure Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2022-2027)
Table Global Biosimilar Monoclonal Antibodies Sales Forecast by Regions (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Market Share Forecast by Regions (2017-2022)
Figure North America Sales Biosimilar Monoclonal Antibodies Market Forecast (2022-2027)
Figure Europe Sales Biosimilar Monoclonal Antibodies Market Forecast (2022-2027)
Figure Asia-Pacific Sales Biosimilar Monoclonal Antibodies Market Forecast (2022-2027)
Figure South America Sales Biosimilar Monoclonal Antibodies Market Forecast (2022-2027)
Figure Middle East & Africa Sales Biosimilar Monoclonal Antibodies Market Forecast (2022-2027)
Table Global Biosimilar Monoclonal Antibodies Sales Forecast by Type (2022-2027)
Table Global Biosimilar Monoclonal Antibodies Market Share Forecast by Type (2022-2027)
Table Global Biosimilar Monoclonal Antibodies Sales Forecast by Application (2022-2027)
Table Global Biosimilar Monoclonal Antibodies Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Monoclonal Antibodies
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure Author List
Celltrion
Hisun Pharma
Novartis (Sandoz)
Pfizer (Hospira)
Cadila Healthcare
3SBIO
Celgen Biopharma
Dr Reddy's
Torrent Pharmaceuticals
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)